期刊文献+

血浆肾素-血管紧张素-醛固酮水平对胺碘酮转复房颤患者窦性心律效果的影响 被引量:3

Effect of renin-angiotensin-aldosterone system on the results of oral amiodarone reversing the sinus rhythm of patients with persistent atrial fibrillation
下载PDF
导出
摘要 目的研究不同肾素、血管紧张素和醛固酮水平对胺碘酮转律效果的影响。方法对持续性心房颤动患者,在使用胺碘酮转律后,依转律效果分为转律成功组(n=17)和转律未成功组(n=19),比较两组患者血浆肾素、血管紧张素和醛固酮浓度的不同,进一步分析其浓度水平与左心房大小的相关性。结果转律成功组患者血浆肾素、血管紧张素和醛固酮水平显著高于转律未成功组(P<0.01,P<0.05,P<0.05);血浆肾素、血管紧张素和醛固酮水平与左心房直径呈显著正相关(P<0.01)。结论肾素、血管紧张素和醛固酮系统的激活对心房颤动的发生、维持和终止起重要作用。加用血管紧张素转换酶抑制剂可能改善心房颤动的转律效果。 Objective To probe the effect of different concentrations of renin,angiotensin and aldostemne on amiodarones reversing of sinus rhythm in patients with persistent atrial fibrillation. Methods According to the results of amiodarone reversing their sinus rhythm, 36 patients with persistent atrial fibrillation were divided into two groups, successfal group ( n = 17) and unsuccessful group ( n = 19). Serum concentrations of renin-angiotensin-aldostemne of the two groups were compared and their correlations with left atrium diameter were also studied. Results The concentrations of renin, angiotensin and aldosterone in successful group were significantly higher than those of unsuccessful group ( P 〈 0.001, P 〈 0.05 ,and P 〈 0.05 respectively) .The concentrations of renin, angiotensin and aldosterune correlated significantly with the diameter of left atrium ( P 〈 0.01). Conclusion Our results indicate that renin-angiotensin-aldosterone system plays an important role in the initiation, maintenance and termination of atrial fibrillation. Our results also suggest that angiotensin-converting enzyme inhibitors might facilitate rebuilding of the sinus rhythm for patients with persistent atrial fibrillation.
出处 《河北医药》 CAS 2006年第3期174-175,共2页 Hebei Medical Journal
关键词 肾素=血管紧张素=醛固酮系统 胺碘酮 心房颤动 renin-angiotensin-aldosterone system amiodarone atrial fibrillation
  • 相关文献

参考文献10

  • 1Peuhkurinen K,Niemela M,Ylitalo A,et al.Effectiveness of amiodarone as a single oral dose for recent-onset atrial fibrillation.Am J Cardiol,2000,85:462-465.
  • 2赵水平,胡大一.心血管病诊疗指南精读.第1版.北京:人民卫生出版社,2004.218.
  • 3Shi Y,Li D,Tardif JC,et al.Fnalapril effects on atrial remodeling and atrial fibrillation in experinental congestive heart failure.Cardiovascular Research,2002,54:456-461.
  • 4Nakashima H,Kumagai K,Urata H,et al.Angiotensin Ⅱ antagonist prevents electrical modeling in atrial fibrillation.Circulation,2000,101:2612-2617.
  • 5王学东,贾三庆,胡大一,吴永全,邢云丽,陈金玲,杜立杰.心房颤动患者循环血浆肾素、血管紧张素Ⅱ和醛固酮的变化及临床意义[J].中国心血管杂志,2004,9(5):339-341. 被引量:25
  • 6Goette A,Staack T,Rocken C,et al.Increased expression of extracellular signal regulated kinase and angiotension converting enzyme in human atria duing atrial fibrillation.J Am Coll Cardiol,2000,35:1669-1677.
  • 7Li D,Shinagawa K,Pang L,et al.Effects of angiotensin-converting enzyme inhibition on the developnent of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure.Circulation,2001,104:2608-2614.
  • 8Kim S,Iwao H.Molecular and cellular mechanisms of angiotensin Ⅱ -mediated cardiovascular and renal diseases.Pharmacological Reviews,2000,52:11-34.
  • 9Zaman AG,Kearney MT,Schecter C,et al.Angiotensin-converting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation.Am Heart J,2004,147:823-827.
  • 10殷跃辉,刘增长,杨小渝,董军,高大中,佘强,熊杰熙,黄祖荣.小剂量胺碘酮与培哚普利联合治疗阵发性心房颤动的临床疗效[J].中国循环杂志,2004,19(1):19-21. 被引量:45

二级参考文献25

  • 1[1]Roy D,Talajic M,Dorian P, et al. Amiodarnoe to prevent recurrence of atrial fibrillation. Canadian Trial of atrial fibrillation Investigators. N Engl J Med, 2000,342: 913-920.
  • 2[2]Kochiadakis GE, Igoumenidis NE, Marketou ME, et al. Low-dose amiodarone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. Am J Cardiol, 1998,81:995-998.
  • 3[3]Wijffels MCEF, Kirchhof CJHJ, Dorland R, et al. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation, 1995,92:1954-1968.
  • 4[4]Goette A, Honeycutt C,Langberg JJ. Electrical remodeling in atrial fibrillation: time course and mechanisms. Circulation, 1996, 94: 2968-2974.
  • 5[5]Tieleman RG, Langen CDJD, Gelder ICV, et al. Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation, 1997,95:1945-1953.
  • 6[6]Wijffels MCEF, Kirchhol CJHJ, Dorland R, et al. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats:role of neurohumoral changes,ischemia,atrial stretch,and high rate of electrical activation. Circulation, 1997,96: 3710-3720.
  • 7[7]Tieleman RG, Gelder ICV, Crijns HJGM, et al. Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-reduced electrical remodeling of atria? J Am Coll Cardil, 1998,31:167-173.
  • 8[8]Van Den Berg MP, Crijns HJGM, Van Veldhuisen DJ, et al. Effects of lisinopril in patients with heart failure and chronic atrial fibrillation. J Card Fail, 1995,1: 355-364.
  • 9[9]Hideko N, Koickiro K, Hidenori U, et al. Angiotensin Ⅱ antagonist prevents electrical remodeling in atrial fibrillation. Circulation, 2000, 101:2612-2617.
  • 10[10]Goette A, Amdt M, Rocken C, et al. Regulation of angiotensin Ⅱ receptor subtypes during atrial fibrillation in human. Circulation, 2000,101:2678-2681.

共引文献66

同被引文献30

  • 1王学东,贾三庆,胡大一,吴永全,邢云丽,陈金玲,杜立杰.心房颤动患者循环血浆肾素、血管紧张素Ⅱ和醛固酮的变化及临床意义[J].中国心血管杂志,2004,9(5):339-341. 被引量:25
  • 2王学东,贾三庆,胡大一,杜立杰,陈金玲,吴永全,邢云丽.心房颤动患者心房肌组织CYP11B2的mRNA表达及研究[J].中国心血管杂志,2005,10(1):10-13. 被引量:1
  • 3裴德安,李莉,徐志云,邹良健,张宝仁,黄盛东,郝家骅,王志农,陆方林.心房颤动患者心房肌组织醛固酮水平和CYP11B2基因与心房结构重构研究[J].中华心律失常学杂志,2006,10(5):349-354. 被引量:11
  • 4田士军.房颤的研究进展[J].河北医药,2006,28(12):1201-1202. 被引量:3
  • 5Lip GY,Hee FL.Paroxysmal atrial fibrillation[J].Q J Med,2001,94(12):665-678.
  • 6Hughes M,Lip GY.Stroke and thromboembolism in atrial fibrillation:a systematic review of stroke risk factors,risk stratification schema and cost effectiveness data[J].Thromb Haemost,2008,99(2):295-304.
  • 7Hennersdorf MG,Schueller PO,Steiner S,et al.Prevalence of paroxysmal atrial fibrillation depending on the regression of left ventricular hypertrophy in arterial hypertension[J].Hypertens Res,2007 30(6):535-540.
  • 8Pedersen OD,Bagger H,Kober L,et al.On behalf of the TRACE study group:Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction[J].Circulation,1999,100(4):376-380.
  • 9Wachtell K,Lelto M,Gerdts E,et al.Angotensin Ⅱreceptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol:the Losartan Intervention for End Point Reduction in Hypertension(LIFE) study[J].J Am Coll Cardiol,2005,45(5):712-719.
  • 10Klingbeil AU,Schneider M,Martus P,et al.A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension[J].Am J Med,2003,115(1):41-46.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部